CHONGQING CARELIFE PHARMACEUTICAL CO.LTD. (CCP), which is held by YaoPharma Co., Ltd., is a reputable R&D-based APIs supplier in China. CCP owns state-of-the-art facilities and has a new plant compliant with cGMP, ICH and ISPE standards. Covering around 80,000 m2 in national chemical industry park of Changshou district of Chongqing city, the new plant has been inspected and approved by China FDA and US FDA.